Literature DB >> 30355573

Angiotensin converting enzyme inhibitors and lung cancer.

Deirdre Cronin-Fenton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30355573     DOI： 10.1136/bmj.k4337

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  The role of the renin-angiotensin system inhibitors in malignancy: a review.

Authors:  Ju Yang; Xi Yang; Ling Gao; Jie Zhang; Cheng Yi; Ying Huang
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study.

Authors:  Yin Zhang; Mingyang Song; Andrew T Chan; Jeffrey A Meyerhardt; Walter C Willett; Edward L Giovannucci
Journal:  Br J Cancer       Date:  2022-09-22       Impact factor: 9.075

3.  Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension.

Authors:  Jie Wei; Zhiyang Zhou; Zhijie Xu; Shuangshuang Zeng; Xi Chen; Xiang Wang; Wanli Liu; Min Liu; Zhicheng Gong; Yuanliang Yan
Journal:  PeerJ       Date:  2019-12-10       Impact factor: 2.984

Review 4.  Risk of lung cancer and renin-angiotensin blockade: a concise review.

Authors:  Tobias Rachow; Helmut Schiffl; Susanne M Lang
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-24       Impact factor: 4.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.